97 results
Duration of DAPT in high bleeding risk and FFR guided PCI vs. CABG for TVD: a guide to interpreting non-inferiority trials
07 Oct 2022 – From AICT-AsiaPCR 2022
Take advantage of this AICT-AsiaPCR 2022 session to learn in detail about the FAME 3 and MASTER-DAPT trials and how to use their results in daily practice, and to better understand what is behind the term "non-inferiority" and when and how to choose a non-inferiority margin.
Revascularisation for Ischemic heart failure: is PCI as good as CABG?
27 Sep 2022
Pamela Gatto interviews Volkmar Falk, Cardiovascular Surgeon, and Dejan Milasinovic, Interventional Cardiologist, to get their perspective about the results of the REVIVED-BCIS2 trial.
The 3 questions are:
- What were your first thoughts and feelings when the findings from REVIVED were presented at ESC 2022?
- In STICH(es), CABG had a...
BYPASS-CTCA: The value of computed tomography cardiac angiography in improving patient satisfaction and reducing contrast load, procedural duration and complications in patients who had previous CABG undergoing invasive coronary angiography
19 Sep 2022
Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.
It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.
Author
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
PCRonline @ TCT 2022 - Get the international perspective!
12 Sep 2022
Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2022 - check out the list here!
Structural Heart Disease pre-case planning tutorials: Mitral valve TMVR
08 Sep 2022
In this series of tutorials, Gilbert Tang proposes instruction videos on how to use 3mensio for pre-case planning in Mitral Valve-in-Valve TMVR.
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
Structural Heart Disease pre-procedural sizing and planning tutorials: TAVR / TAVI
17 Aug 2022
In this series of tutorials, Gilbert Tang proposes instruction videos on how to use 3mensio for pre-procedural sizing and planning in TAVR, Valve-in-Valve, re-do TAVR, alternate access and more.
Prognostic impact of extra–mitral valve cardiac involvement in patients with primary mitral regurgitation
17 Jun 2022
This report builds up the evidence on the relevance of extra-valvular cardiac damage staging / involvement as a main predictor of adverse events in patients with VHD undergoing intervention, either surgical or percutaneous.
Reviewer
Reviewer
Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial
16 Jun 2022
The UK TAVI trial sought to compare TAVI with SAVR in patients with severe, symptomatic aortic stenosis and moderately increased surgical risk.
Reviewer
